IRIS
NARDONE, OLGA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.609
NA - Nord America 3.082
EU - Europa 1.901
SA - Sud America 382
Continente sconosciuto - Info sul continente non disponibili 160
AF - Africa 93
OC - Oceania 10
Totale 9.237
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.916
SG - Singapore 1.569
RU - Federazione Russa 852
CN - Cina 790
VN - Vietnam 564
IT - Italia 479
BR - Brasile 303
HK - Hong Kong 245
BD - Bangladesh 126
FR - Francia 107
DE - Germania 104
NL - Olanda 91
CA - Canada 85
GB - Regno Unito 76
KR - Corea 68
IN - India 58
JP - Giappone 51
FI - Finlandia 40
AR - Argentina 28
MX - Messico 27
PL - Polonia 26
IE - Irlanda 25
ZA - Sudafrica 24
CI - Costa d'Avorio 19
ID - Indonesia 18
TH - Thailandia 17
CO - Colombia 14
PH - Filippine 14
RO - Romania 13
TR - Turchia 13
BG - Bulgaria 12
EC - Ecuador 12
UA - Ucraina 12
IQ - Iraq 11
UZ - Uzbekistan 11
CR - Costa Rica 10
VE - Venezuela 10
ES - Italia 9
JM - Giamaica 9
MA - Marocco 9
PK - Pakistan 9
SE - Svezia 9
AT - Austria 8
EG - Egitto 8
KZ - Kazakistan 7
TT - Trinidad e Tobago 7
KE - Kenya 6
MY - Malesia 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
NI - Nicaragua 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DZ - Algeria 4
GT - Guatemala 4
HN - Honduras 4
LT - Lituania 4
NG - Nigeria 4
PE - Perù 4
SC - Seychelles 4
TN - Tunisia 4
CW - ???statistics.table.value.countryCode.CW??? 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EE - Estonia 3
JO - Giordania 3
LB - Libano 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SV - El Salvador 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
AW - Aruba 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CU - Cuba 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
IR - Iran 1
KW - Kuwait 1
KY - Cayman, isole 1
Totale 9.063
Salva come PNG Salva come JPEG
Città #
Singapore 786
San Jose 541
Hefei 342
Ashburn 287
Hong Kong 235
Moscow 224
Council Bluffs 168
Chandler 164
Beijing 162
Ho Chi Minh City 159
Hanoi 141
Naples 119
Santa Clara 113
The Dalles 107
Los Angeles 88
Lauterbourg 68
Seoul 63
New York 58
Phoenix 58
Amsterdam 51
Tokyo 44
Buffalo 34
Dallas 34
São Paulo 31
Redondo Beach 30
Milan 29
Haiphong 27
Munich 27
Millbury 26
Napoli 26
Rome 25
Frankfurt am Main 23
Da Nang 22
Toronto 22
Chicago 21
Montreal 20
Boston 19
Helsinki 19
Brooklyn 18
Seattle 18
Warsaw 18
Des Moines 15
Nanjing 15
Orem 15
Boardman 14
Atlanta 13
Johannesburg 12
Princeton 12
Sofia 12
Denver 11
Dublin 10
Kochi 10
Lawrence 10
Mexico City 10
Nuremberg 10
Redwood City 10
Tashkent 10
Can Tho 9
Houston 9
London 9
Rio de Janeiro 9
Wilmington 9
Bangkok 8
Düsseldorf 8
New Delhi 8
San Francisco 8
Catania 7
Elk Grove Village 7
Florence 7
Jiaxing 7
Kingston 7
Miami 7
Ottawa 7
Rochdale 7
San José 7
Thái Bình 7
Thái Nguyên 7
Turku 7
Vienna 7
Ankara 6
Bogotá 6
Bucharest 6
Charlotte 6
Hải Dương 6
Kronberg 6
Memphis 6
Nairobi 6
Quito 6
Turin 6
Belo Horizonte 5
Bexley 5
Bắc Ninh 5
Chennai 5
Dhaka 5
Lappeenranta 5
Managua 5
Manchester 5
Ninh Bình 5
Palermo 5
Pittsburgh 5
Totale 4.939
Salva come PNG Salva come JPEG
Nome #
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents 175
Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience 175
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with biologics 174
Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index 172
Bowel damage in Crohn's disease: direct comparison of ultrasonography- and magnetic resonance-based Lemann index. 170
Multi-detector CT enterography in active inflammatory bowel disease: Image quality and diagnostic efficacy of a low-radiation high contrast protocol 167
Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis 162
Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography 162
Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease 161
Adherence in ulcerative colitis: an overview 160
Diagnostic Accuracy of Ultrasonography in the Detection of Postsurgical Recurrence in Crohn's Disease: A Systematic Review with Meta-analysis 158
Different profile of efficacy of thiopurines in ulcerative colitis and Crohn's disease 158
Psoriasis Features in Patients with Inflammatory Bowel Disease 157
Gut microbiota and Crohn's disease 154
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 154
Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases 151
The impact of a dedicated contact centre on the clinical outcome of patients with inflammatory bowel disease during the COVID-19 outbreak 151
The burden of anaemia in patients with inflammatory bowel diseases 148
The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease 146
Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers 145
Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives 143
One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing. 139
Effectiveness of Partial Enteral Nutrition as Add-On to Biologics in Patients With Refractory and Difficult-to-Treat Crohn’s Disease: A Pilot Study 138
Combined endoscopic/sonographic-based risk matrix model for predicting one-year risk of surgery: A prospective observational study of a tertiary centre severe/refractory crohn's disease cohort 138
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold 137
Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition 137
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers 135
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study 133
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection 131
Gut microbiota and irritable bowel syndrome 129
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study 125
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 125
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 118
David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease 118
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 116
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis 111
Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models? 111
Rates of Endoscopic Recurrence In Postoperative Crohn's Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis 109
Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era 109
Insights into disability and psycho-social care of patients with inflammatory bowel disease 106
Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting. 104
Objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients failure to TNF-alpha inhibitors 104
The Impact of Intestinal Ultrasound on the Management of Inflammatory Bowel Disease: From Established Facts Toward New Horizons 102
Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease 99
Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study 94
Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials 87
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis 82
Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy 79
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey 78
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 76
Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis 75
Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey 72
New endoscopic tools in inflammatory bowel disease 71
Venous and arterial thromboembolism in out-patients with inflammatory bowel disease: a single center study. 71
Advancing perioperative optimization in Crohn's disease surgery with machine learning predictions 69
Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease? 67
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis 66
Image-Enhanced Endoscopy Surveillance of Colon and Pouch Dysplasia in IBD 65
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab 64
Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study 64
A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis 64
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?-Author's reply 64
Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video) 64
Small molecule oral targeted therapies in ulcerative colitis 63
Key challenges and care approaches in inflammatory pouch disorders: What can we do better? 62
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 61
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 60
Image-Enhanced Endoscopy in the Surveillance of Colitis-Associated Neoplasia 59
Endocytoscopy with automated multispectral intestinal barrier pathology imaging for assessment of deep healing to predict outcomes in ulcerative colitis 59
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 58
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 57
MMX mesalamine: A modern twist on a classic treatment 55
Heterogeneity of definition of upper gastrointestinal tract in different guidelines of Crohn's disease: A scoping review 55
Addressing unmet needs of gastroenterologists' training in the post-COVID-19 era 54
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year 53
Real-world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey 53
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients 52
Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative 50
Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy 50
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialists 49
Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease 49
Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission 48
Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research 47
AI and endoscopy/histology in UC: the rise of machine 46
The Impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International Study 43
Sarcopenia: A new route on the map for risk stratification in inflammatory bowel disease 43
Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease 39
The role of fecal calprotectin in assessing response to advanced medical treatments for inflammatory bowel diseases: a review of the literature 28
Risk of avoidant/restrictive food intake disorders in patients with inflammatory bowel disease: a matched cross-sectional case-control study 25
Inflammatory Bowel Diseases and Nephropathies: Exploring the Gut–Kidney Axis 25
Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study 25
Adiponectin and phase angle in the assessment of sarcopenia in Crohn’s disease: beyond muscle mass 24
Comparative analysis of sporadic, IBD-associated, early-onset and late-onset colorectal cancer: a systematic review and meta-analysis 23
Prevalence of disability in inflammatory bowel disease: a systematic review and meta-analysis 23
Artificial Intelligence in Advancing Inflammatory Bowel Disease Management: Setting New Standards 22
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class 22
ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1 21
Advanced diagnostic and resection endoscopic techniques in managing colitis-associated neoplasia: standard of care or still utopia? 21
Unveiling the effectiveness of Chat-GPT 4.0, an artificial intelligence conversational tool, for addressing common patient queries in gastrointestinal endoscopy 20
Global perspectives on sustainable IBD care 19
Totale 9.052
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.912
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022181 0 0 0 2 1 2 0 9 12 12 52 91
2022/2023333 30 44 6 29 43 38 3 30 42 46 15 7
2023/2024335 7 35 15 15 10 28 62 45 6 5 69 38
2024/20252.152 108 101 6 16 65 108 266 124 125 242 778 213
2025/20265.037 459 534 565 460 661 175 496 263 673 321 198 232
2026/2027929 179 231 267 252 0 0 0 0 0 0 0 0
Totale 9.237